tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR
US Market
Advertisement

Pharming Group (PHAR) Technical Analysis

Compare
153 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Pharming Group’s (PHAR) Moving Averages Convergence Divergence (MACD) indicator is 0.45, suggesting Pharming Group is a Buy.
Pharming Group’s (PHAR) 20-Day exponential moving average is 14.67, while Pharming Group’s (PHAR) share price is $15.38, making it a Sell.
Pharming Group’s (PHAR) 50-Day exponential moving average is 13.66, while Pharming Group’s (PHAR) share price is $15.38, making it a Buy.

Pharming Group (PHAR) Pivot Points

Oct 08, 2025, 01:59 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.35
14.74
15.06
15.45
15.77
16.16
16.48
Fibonacci
14.74
15.01
15.18
15.45
15.72
15.89
16.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharming Group (PHAR) Moving Averages

Oct 08, 2025, 01:59 PM
Period
Simple
Exponential
MA5
15.36Sell
15.11Sell
MA10
14.88Sell
14.97Sell
MA20
14.63Buy
14.67Sell
MA50
13.54Buy
13.66Buy
MA100
12.07Buy
12.42Buy
MA200
10.50Buy
10.98Buy
Pharming Group’s (PHAR) 10-Day exponential moving average is 14.97, while Pharming Group’s (PHAR) share price is $15.38, making it a Sell.
Pharming Group’s (PHAR) 100-Day exponential moving average is 12.42, while Pharming Group’s (PHAR) share price is $15.38, making it a Buy.
Pharming Group’s (PHAR) stock price is $15.38 and Pharming Group’s (PHAR) 50-day simple moving average is 13.54, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $15.38 and Pharming Group’s (PHAR) 100-day simple moving average is 12.07, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $15.38 and Pharming Group’s (PHAR) 200-day simple moving average is 10.50, creating a Buy signal.

Pharming Group (PHAR) Technical Indicators

Oct 08, 2025, 01:59 PM
Name
Value
Implied Action
RSI (14)
51.64
Neutral
STOCH (9,6)
71.37
Neutral
STOCHRSI (14)
71.37
Neutral
MACD (12,26)
0.45
Buy
ADX (14)
19.92
Buy
Williams %R
-51.92
Buy
CCI (14)
11.91
Neutral
ATR (14)
0.93
-
Ultimate Oscillator
50.02
Neutral
ROC
0.48
Buy
Pharming Group’s (PHAR) Relative Strength Index (RSI) is 51.64, creating a Neutral signal.
Pharming Group’s (PHAR) Trend Strength Indicator (ADX) is 19.92, creating a Buy signal.
Pharming Group’s (PHAR) Commodity Channel Index (CCI) is 11.91, creating a Neutral signal.
Pharming Group’s (PHAR) Price Rate of Change (ROC) is 0.48, creating a Buy signal.

FAQ

Is PHAR a Buy, Hold, or Sell?
Based on PHAR’s technical indicators, PHAR is a Buy.
    What is PHAR’s RSI (14)?
    PHAR’s RSI (14) is 51.64, which suggests PHAR is a Neutral.
      What is PHAR’s MACD?
      PHAR’s MACD is 0.45, which suggests PHAR is a Buy.
        What is PHAR’s 5-day moving average?
        PHAR’s 5-day moving average is 15.36, which suggests PHAR is a Sell.
          What is PHAR’s 20-day moving average?
          PHAR 20-day moving average is 14.63, which suggests PHAR is a Buy.
            What is PHAR’s 50-day moving average?
            PHAR’s 50-day moving average is 13.54, which suggests PHAR is a Buy.
              What is PHAR’s 200-day moving average?
              PHAR’s 200-day moving average is 10.50, which suggests PHAR is a Buy.
                What is PHAR’s Williams % R (14)?
                PHAR’s Williams % R (14) is -51.92, which suggests PHAR is a Buy.
                  What is PHAR’s CCI (14)?
                  PHAR’s CCI (14) is 11.91, which suggests PHAR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis